Net Cash Provided by (Used in) Operating Activities in USD of CANNAPHARMARX, INC. from Q1 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
CANNAPHARMARX, INC. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and change rate from Q1 2010 to Q1 2025.
  • CANNAPHARMARX, INC. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was -$601K, a 9.58% decline year-over-year.
  • CANNAPHARMARX, INC. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$1.7M, a 25.4% increase from 2023.
  • CANNAPHARMARX, INC. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$2.27M, a 57% decline from 2022.
  • CANNAPHARMARX, INC. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$1.45M, a 40% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

CANNAPHARMARX, INC. Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$601K -$52.6K -9.58% 01 Jan 2025 31 Mar 2025 10-Q 16 May 2025
Q1 2024 -$549K +$62.9K +10.3% 01 Jan 2024 31 Mar 2024 10-Q 16 May 2025
Q1 2023 -$612K -$237K -63.1% 01 Jan 2023 31 Mar 2023 10-Q 25 Jun 2024
Q1 2022 -$375K +$424K +53.1% 01 Jan 2022 31 Mar 2022 10-Q 22 Sep 2023
Q1 2021 -$799K -$434K -119% 01 Jan 2021 31 Mar 2021 10-Q 23 May 2022
Q1 2020 -$366K -$189K -107% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021
Q1 2019 -$177K -$177K 01 Jan 2019 31 Mar 2019 10-Q 29 Jun 2020
Q1 2018 $0 $0 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q1 2017 $0 +$17.6K 01 Jan 2017 31 Mar 2017 10-Q 14 Sep 2018
Q1 2016 -$17.6K +$630K +97.3% 01 Jan 2016 31 Mar 2016 10-Q 14 Sep 2018
Q1 2015 -$648K -$642K -10610% 01 Jan 2015 31 Mar 2015 10-Q 14 Sep 2018
Q1 2014 -$6.05K -$647 -12% 01 Jan 2014 31 Mar 2014 10-Q 19 May 2014
Q1 2013 -$5.4K +$200 +3.57% 01 Jan 2013 31 Mar 2013 10-Q 19 May 2014
Q1 2012 -$5.6K +$9.4K +62.7% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013
Q1 2011 -$15K $0 0% 01 Jan 2011 31 Mar 2011 10-Q 01 Jul 2011
Q1 2010 -$15K 01 Jan 2010 31 Mar 2010 10-Q 01 Jul 2011

CANNAPHARMARX, INC. Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$1.7M +$577K +25.4% 01 Jan 2024 31 Dec 2024 10-K 10 Apr 2025
2023 -$2.27M -$826K -57% 01 Jan 2023 31 Dec 2023 10-K 10 Apr 2025
2022 -$1.45M +$966K +40% 01 Jan 2022 31 Dec 2022 10-K 01 Sep 2023
2021 -$2.41M -$1.85M -328% 01 Jan 2021 31 Dec 2021 10-K 01 Sep 2023
2020 -$564K +$3.23M +85.1% 01 Jan 2020 31 Dec 2020 10-K 15 Apr 2022
2019 -$3.79M -$2.85M -303% 01 Jan 2019 31 Dec 2019 10-K 14 Apr 2021
2018 -$941K -$941K 01 Jan 2018 31 Dec 2018 10-K 27 May 2020
2017 $0 +$22.4K 01 Jan 2017 31 Dec 2017 10-K 03 Apr 2019
2016 -$22.4K +$2.53M +99.1% 01 Jan 2016 31 Dec 2016 10-K 14 Sep 2018
2015 -$2.55M -$1.01M -65.4% 01 Jan 2015 31 Dec 2015 10-K 14 Sep 2018
2014 -$1.54M 01 Jan 2014 31 Dec 2014 10-K 11 Sep 2018
2012 -$10.9K +$1.19K +9.84% 01 Jan 2012 31 Dec 2012 10-K 28 Mar 2013
2011 -$12.1K -$12.1K 01 Jan 2011 31 Dec 2011 10-K 28 Mar 2013
2010 $0 01 Jan 2010 31 Dec 2010 10-K 14 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.